CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Randomized Phase II Study of Pemetrexed Versus Gefitinib in Previously Treated Patients with Advanced Non-small Cell Lung Cancer
Young Saing Kim, Eun Kyung Cho, Hyun Sun Woo, Junshik Hong, Hee Kyung Ahn, Inkeun Park, Sun Jin Sym, Sun Young Kyung, Shin Myung Kang, Jeong-Woong Park, Sung Hwan Jeong, Jinny Park, Jae Hoon Lee, Dong Bok Shin
Cancer Research and Treatment. 2016;48(1):80-87.   Published online 2015 March 2    DOI: https://doi.org/10.4143/crt.2014.307

Excel Download

Randomized Phase II Study of Pemetrexed Versus Gefitinib in Previously Treated Patients with Advanced Non-small Cell Lung Cancer
Cancer Research and Treatment. 2016;48(1):80-87   Crossref logo
Link1 Link2 Link3

Results of a clinical multicentric randomized phase II study of non-small cell lung cancer treated with vinorelbine-cisplatin versus vinorelbine alone
Lung Cancer. 1995;12(3):307   Crossref logo
Link1 Link2

Phase II trial of gallium nitrate in previously treated patients with small cell lung cancer
Lung Cancer. 1994;10(5-6):420   Crossref logo
Link1 Link2

Randomized phase II study of gefitinib versus erlotinib in patients with advanced non-small cell lung cancer who failed previous chemotherapy
Lung Cancer. 2012;75(1):82-88   Crossref logo
Link1 Link2

Phase II study of iproplatin (CHIP) in previously treated small-cell lung cancer
Lung Cancer. 1990;6(1-2):58   Crossref logo
Link1 Link2

Phase I/II study of gefitinib (Iressa®) and vorinostat (IVORI) in previously treated patients with advanced non-small cell lung cancer
Cancer Chemotherapy and Pharmacology. 2015;75(3):475-483   Crossref logo
Link1 Link2 Link3

A randomized phase II study of bortezomib and pemetrexed, in combination or alone, in patients with previously treated advanced non-small-cell lung cancer
Lung Cancer. 2010;68(3):420-426   Crossref logo
Link1 Link2

Phase II studies of topotecan in patients with non-small cell lung cancer (NSCLC) previously untreated and patients with small cell lung (SCLC) cancer refractory to etoposide
Lung Cancer. 1994;11:126   Crossref logo
Link1 Link2

Sunitinib Plus Erlotinib Versus Placebo Plus Erlotinib in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer: A Phase III Trial
Yearbook of Oncology. 2012;2012:187-188   Crossref logo
Link1 Link2

Publisher’s Note ‘Phase 2 Study of the Focal Adhesion Kinase Inhibitor Defactinib (VS-6063) in Previously Treated Advanced KRAS Mutant Non-small Cell Lung Cancer’
Lung Cancer. 2020;139:169   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.